178 related articles for article (PubMed ID: 23612359)
1. Comparison of systemic absorption between ofloxacin ophthalmic in situ gels and ofloxacin conventional ophthalmic solutions administration to rabbit eyes by HPLC-MS/MS.
Li J; Zhao H; Okeke CI; Li L; Liu Z; Yin Z; Zhuang P; Sun J; Wu T; Wang M; Li N; Pi J; Zhang Q; Zhang R; Ma L; Pang X; Liu Z; Zhang L; Fan L
Int J Pharm; 2013 Jun; 450(1-2):104-13. PubMed ID: 23612359
[TBL] [Abstract][Full Text] [Related]
2. Determination of ofloxacin in tear by HPLC-ESI-MS/MS method: comparison of ophthalmic drug release between a new mucoadhesive chitosan films and a conventional eye drop formulation in rabbit model.
Byrro RM; de Oliveira Fulgêncio G; da Silva Cunha A; César IC; Chellini PR; Pianetti GA
J Pharm Biomed Anal; 2012 Nov; 70():544-8. PubMed ID: 22673938
[TBL] [Abstract][Full Text] [Related]
3. Absorption of topically administered ciprofloxacin, ofloxacin and gentamicin in the inflamed rabbit eye.
Behrens-Baumann W
Ophthalmologica; 1996; 210(2):119-22. PubMed ID: 8859488
[TBL] [Abstract][Full Text] [Related]
4. Hydrogel Ring for Topical Drug Delivery to the Ocular Posterior Segment.
Shikamura Y; Yamazaki Y; Matsunaga T; Sato T; Ohtori A; Tojo K
Curr Eye Res; 2016 May; 41(5):653-61. PubMed ID: 26237665
[TBL] [Abstract][Full Text] [Related]
5. Antibiotic effects of WP-0405, a thermo-setting ofloxacin gel, on methicillin-resistant Staphylococcus aureus keratitis in rabbits.
Fukaya Y; Kurita A; Tsuruga H; Naito A; Nakaya S; Sato M; Kamata Y; Hirata H; Kambara Y; Kurasawa N; Wada T; Toyoda Y; Shirasawa E; Ohashi Y
J Ocul Pharmacol Ther; 2006 Aug; 22(4):258-66. PubMed ID: 16910867
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic efficacy of ophthalmic quinolones in experimental endophthalmitis in rabbits.
Wada T; Kozai S; Tajika T; Sakaki H; Suzuki T; Ohashi Y
J Ocul Pharmacol Ther; 2008 Jun; 24(3):278-89. PubMed ID: 18462067
[TBL] [Abstract][Full Text] [Related]
7. Sustained ophthalmic delivery of ofloxacin from an ion-activated in situ gelling system.
Abraham S; Furtado S; Bharath S; Basavaraj BV; Deveswaran R; Madhavan V
Pak J Pharm Sci; 2009 Apr; 22(2):175-9. PubMed ID: 19339228
[TBL] [Abstract][Full Text] [Related]
8. Formulation and development of ophthalmic in situ gel for the treatment ocular inflammation and infection using application of quality by design concept.
Patel N; Thakkar V; Metalia V; Baldaniya L; Gandhi T; Gohel M
Drug Dev Ind Pharm; 2016 Sep; 42(9):1406-23. PubMed ID: 26716613
[TBL] [Abstract][Full Text] [Related]
9. Tear concentration and safety of levofloxacin ophthalmic solution 1.5% compared with ofloxacin ophthalmic solution 0.3% after topical administration in healthy adult volunteers.
Walters T; Rinehart M; Krebs W; Holdbrook M
Cornea; 2010 Mar; 29(3):263-8. PubMed ID: 20098307
[TBL] [Abstract][Full Text] [Related]
10. Increasing efficacy and reducing systemic absorption of brimonidine tartrate ophthalmic gels in rabbits.
Pang X; Li J; Pi J; Qi D; Guo P; Li N; Wu Y; Liu Z
Pharm Dev Technol; 2018 Mar; 23(3):231-239. PubMed ID: 28488447
[TBL] [Abstract][Full Text] [Related]
11. [Time course of changes in functional visual acuity and ocular wavefront aberration after instillation of ofloxacin gel-forming ophthalmic solution].
Yamamoto T; Hiraoka T; Oshika T
Nippon Ganka Gakkai Zasshi; 2011 Dec; 115(12):1094-100. PubMed ID: 22312814
[TBL] [Abstract][Full Text] [Related]
12. Ocular pharmacokinetics profile of different indomethacin topical formulations.
Bucolo C; Melilli B; Piazza C; Zurria M; Drago F
J Ocul Pharmacol Ther; 2011 Dec; 27(6):571-6. PubMed ID: 22059858
[TBL] [Abstract][Full Text] [Related]
13. The effect of the corneal epithelium on the intraocular penetration of fluoroquinolone ophthalmic solution.
Fukuda M; Inoue A; Sasaki K; Takahashi N
Jpn J Ophthalmol; 2004; 48(2):93-6. PubMed ID: 15060787
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of ofloxacin in broiler chicken.
Kalaiselvi L; Sriranjani D; Ramesh S; Sriram P; Mathuram LN
J Vet Pharmacol Ther; 2006 Jun; 29(3):185-9. PubMed ID: 16669862
[TBL] [Abstract][Full Text] [Related]
15. Improving the ocular to systemic ratio of topical timolol by varying the dosing time.
Ohdo S; Grass GM; Lee VH
Invest Ophthalmol Vis Sci; 1991 Sep; 32(10):2790-8. PubMed ID: 1894477
[TBL] [Abstract][Full Text] [Related]
16. Topical and systemic absorption in delivery of dexamethasone to the anterior and posterior segments of the eye.
Sigurdsson HH; Konráethsdóttir F; Loftsson T; Stefánsson E
Acta Ophthalmol Scand; 2007 Sep; 85(6):598-602. PubMed ID: 17645424
[TBL] [Abstract][Full Text] [Related]
17. Ocular penetration of levofloxacin, ofloxacin and ciprofloxacin in eyes with functioning filtering blebs: investigator masked, randomised clinical trial.
Cantor LB; WuDunn D; Yung CW; Valluri S; Catoira YP; Hoop JS; Morgan LS
Br J Ophthalmol; 2008 Mar; 92(3):345-7. PubMed ID: 18211932
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of topical taurolidine versus ciprofloxacin, ofloxacin, and fortified cefazolin in a rabbit Staphylococcus aureus keratitis model.
Oguz H; Ozbilge H; Oguz E; Gurkan T
Curr Eye Res; 2005 Mar; 30(3):155-61. PubMed ID: 15804740
[TBL] [Abstract][Full Text] [Related]
19. Ocular absorption, distribution, and systemic absorption of a novel antiglaucoma medication, prostaglandin derivative, in male white rabbits.
Higaki K; Kamata K; Takeuchi M; Inazawa K; Chikai T; Hamaguchi T; Yukawa T; Kadono K; Kawahara S; Nakano M
Drug Metab Dispos; 1995 Jan; 23(1):35-43. PubMed ID: 7720522
[TBL] [Abstract][Full Text] [Related]
20. Thermoresponsive ophthalmic poloxamer/tween/carbopol in situ gels of a poorly water-soluble drug fluconazole: preparation and in vitro-in vivo evaluation.
Lihong W; Xin C; Yongxue G; Yiying B; Gang C
Drug Dev Ind Pharm; 2014 Oct; 40(10):1402-10. PubMed ID: 23944837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
